Global Obesity Treating Neuromodulation System Market Professional Survey Report 2019
Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
The global Obesity Treating Neuromodulation System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Obesity Treating Neuromodulation System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obesity Treating Neuromodulation System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Obesity Treating Neuromodulation System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Obesity Treating Neuromodulation System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
Cyberonics
St. Jude Medical
BioControl Medical
Leptos Medical
EnteroMedics
Nevro
Nuvectra
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
The global Obesity Treating Neuromodulation System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Obesity Treating Neuromodulation System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Obesity Treating Neuromodulation System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Obesity Treating Neuromodulation System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Obesity Treating Neuromodulation System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Medtronic
Cyberonics
St. Jude Medical
BioControl Medical
Leptos Medical
EnteroMedics
Nevro
Nuvectra
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
